{"Clinical Trial ID": "NCT03618017", "Intervention": ["INTERVENTION 1:", "\u2022 Recruited population", "Recruitment and registration in predominance"], "Eligibility": ["Incorporation criteria:", "- Early breast cancer diagnosis (0-IIB)", "To be a patient of a breast cancer oncologist at the University of Michigan", "The primary treatment of cancer must be completed and the transition to survival must be completed.", "You have to be able to speak, read and write in English.", "Must have access and the ability to use the Internet", "- Exclusion criteria:", "Stage III or IV breast cancer diagnosis", "Unable to speak, read and write in English"], "Results": ["Performance measures:", "Number of successfully recruited breast cancer patients to participate in the study", "We expect a response rate of 80% (n=60) and will assess the number of successful patients enrolled and completing the baseline survey.", "Timeline: During the baseline survey", "Results 1:", "Title of arm/group: Recruited population", "Description of Arm/Group: Recruitment and Registration for Predominance", "Total number of participants analysed: 160", "Type of measure: Number of participants", "Unit of measure: Participants 66 41.3%"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/33 (0.00 per cent)"]}